Cervical cancer screening problems and barriers in Lithuania Presented by Ruta Kurtinaitiene Tallin April 2, 2007.

Slides:



Advertisements
Similar presentations
National Cancer Screening Programmes Bowel Screening Breast Screening Cervical Screening.
Advertisements

1 THE POSSIBLE INFLUENCE OF THE MEDICAL STAFF INVOLVED IN THE ORGANIZED CERVICAL CANCER (CC) SCREENING OVER THE RESPONSIVENESS TO THE CENTRALLY ISSUED.
Public Health Programme EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL EUROCHIP-3 WP-4 Update EUROCHIP: EUROpean Cancer Health Indicator.
Annie Emery Acting Director of Business Development The Lesbian & Gay Foundation Are You Ready For Your Screen Test?
Italian Cervical Screening Programme. 17ème congrés de la Société Marocaine de Cancerologie Avril, Marrakech Marco Zappa ISPO, Scientific Institute.
THE EUROCHIP PROJECTS Health Indicators for Health Indicators for Monitoring Cancer in Europe
PROPHYLAXIS AND CERVICAL SCREENING IN BULGARIA- PAST, PROBLEMS AND FUTURE Dr. Petya Kostova, PhD Gynecology Clinic, National Oncology Hospital, Sofia;
Manitoba Cervical Cancer Screening Program April 2010.
MS&E 220 Project Yuan Xiang Chew, Elizabeth A Hastings, Morris Jinhui Zhang Probabilistic Analysis of Cervical Cancer Screening and Vaccination.
Cervical Cancer Screening Assessment in Romania- Problems, Present, Future Iuliana Apostol, MD Dr Victor Babes Foundation, Bucharest, Romania.
ANNE MURUGI1,2 1.Amref Health Africa 2.University of Nairobi
By: Jennifer Cox.  HPV is the most common sexually transmitted disease affecting more than 20 million people in the U.S.  HPV is responsible for 70%
Cervical cancer screening in Estonia: present situation Piret Veerus Department of Epidemiology and Biostatistics National Institute for Health Development.
Cervical cancer screening problems and barriers in Latvia
PROJECT Situation analysis and cost- effectiveness analysis of cervical cancer screening in Russia Coordinator of the project: N. Koroleva.
1 Cervical Cancer Screening in Latvia: Present, Problems and Future Ilze Viberga, MD, PhD, Ob/Gyn.
 One of Miami-Dade County’s preeminent federally qualified community healthcare center.  Mission: To provide comprehensive primary health care services.
EUROCHIP-2 European Public Health Action on Cervical Cancer Screening GRELL Palma de Majorca Public Health Program EUROPEAN COMMISSION: HEALTH &
January is Cervical Health Awareness Month. Mt. Prospect Health Ministry wants you to know that there’s a lot you can do to prevent cervical cancer.
HPV & Cervical Cancer Frequently Asked Questions HPV & Cervical Cancer Prevention 2009 International Toolkit.
STRENGTHENING CENTER FOR PREVENTION IN PRIMARY HEALTH CARE CENTER “ZEMUN” Dr Olivera M. ĆIRKOVIĆ Dr Olivera M. ĆIRKOVIĆ Prof. dr Milica Prostran Dr Mladen.
DISCUSSIONS and DECISIONS Sophia, 22 nd May 2006 Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE - GENERAL
Women’s First Health Center Drs. Sylvester, Youngren, Lo and Sansobrino What You Should Know About Cervical Cancer: Part one in a series of four updates.
Cervical Sample Taker Training 2015 THE NHS CERVICAL SCREENING PROGRAMME (NHSCSP)
NOT ALL PAST SUCCESSES IN CANCER RESEARCH HAVE BEEN FOLLOWED BY ACTIONS EUROCHIP-2 THE ACTION Project & news EUROCHIP-2 THE ACTION Project & news Public.
Epidemiology of a Chronic Disease Exercise By Mary Murphy April 2008
Preventing the Spread of HPV with Fact Check: HPV A Novel Facebook Application Christianne Johnson, MA, CHES Program Manager, Partnership for Prevention.
Cervical Cancer Screening Recommendations 2012, FDA Panel 2014.
DISCUSSION. EUROCHIP-2 ACTION PLAN COUNTRY 1COUNTRY 2COUNTRY 3 COUNTRY 30 ACTION1ACTION1 ACTION2ACTION2 ACTION3ACTION3 ACTION3ACTION3 ACTION4ACTION4 ACTION4ACTION4.
Multifaceted HPV Vaccination Strategies in California Achieving the Promise Avoiding the Pitfalls Heidi M. Bauer, MD MS MPH California Department of Public.
1 Cervical cancer screening in Lithuania 2005 Maiori, Italy Juozas Kurtinaitis Institute of Oncology, Vilnius University
Cancer Care Ontario A Organizational Overview S Orientation Workshop July 16, 2014 Sheila M Densham, BA, TEACH Health Promotion Coordinator.
Cancer Healthy Kansans 2010 Steering Committee Meeting May 12, 2005.
PERIODIC MEDICAL EXAMINATION BY DR. ANGELA ESOIMEME MBBS, MPH, FWACGP.
HPV VACCINATION Dr Frida Mghamba 2 nd East Africa WE CAN Summit 11 th September 2014.
Reporting women’s attitudes to preventive gynaecological healthcare: survey of more than 6000 women in three European countries EUROGIN February.
EUROCHIP-2 EUROCHIP-2 - The Action Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL.
Cervical cancer screening: problems and barriers in Estonia Piret Veerus Department of Epidemiology and Biostatistics National Institute for Health Development.
AGE DIFFERENCE IN CERVICAL NEOPLASIA DISTRIBUTION AMONG WOMEN ATTENDING A HOSPITAL BASED AND PERIPHERAL SCREENING PROGRAMMES Dr.Kalavathy Mathurchennath1,
Factors associated with abnormal PAP Smears in a health center X – Costa Rica, 2009 Leandra Abarca 1, Julia Freer 1, Maricela Salas 2 1, MD, MsC, FETP,
EUROCHIP-2 results in Lithuania Varenna October 18, 2007 Presented by Ruta Kurtinaitiene
THANKS Project Pilot Questionnaire Results at RCT Zagreb.
HPV and Cervical Cancer FAQ. What is cervical cancer? Cervical cancer is cancer of the cervix, the part of the uterus or womb that opens to the vagina.
Dr Andrea Micheli Descriptive Epidemiology and Health Planning Unit Fondazione IRCCS “Istituto Nazionale dei Tumori” Milan Public Health Programme EUROPEAN.
Dr.Hana Kadhom 2015 Knowledge of HPV infection and awareness of risk factors among University students in Bahrain Dr. Hana Kadhom October
Study on global AGEing and adult health (SAGE) | 1 |1 | Health of older Ghanaians: Health Risks and Chronic Non-communicable Diseases Dr Alfred E Yawson.
Janet Lin, MD, MPH, Sweta Basnet, MS, Sara Baghikar, MD, Cammeo Mauntel-Medici, MPH, Sara Heinert, MPH University of Illinois at Chicago, College of Medicine,
Cervical cancer: STUDY TO INCREASE ATTENDANCE RATE AT SCREENING ISPRA, : Presented by R. Kurtinaitiene M. D., PhD Vilnius University.
Women’s sector progress report and plans Implementing the NSP Inter Parliamentary Union 22 January 2009 Nomfundo Eland.
Fight against cervical cancer Flemish Minister Steven Vanackere Welfare, Public Health and Family.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
2015 Afghanistan Demographic and Health Survey (AfDHS) Key Indicators Report.
Cancer Research UK Established in 2004 Largest research charity in Europe Funded entirely by the general public Funds more than half of all cancer research.
Cervical Cancer How We Can Prevent It Dr Quek Swee Chong Himalayan Women’s Health Project 30 August 2014.
WACCPP rolling PowerPoint. INSTRUCTIONS  This PowerPoint presentation has been designed for use as a rolling backdrop at presentations or events  Before.
Strategies for Monitoring the Impact of HPV Vaccination Using Population-Based Data Rain Mocello, MPH California DPH STD Control Branch.
“Take the Test: Not the Risk” HPV and Cervical Cancer Cervical Cancer is Preventable!
For the EUROCHIP-3 project
University of Rajarata.
School of Life and Health Sciences, University of Ulster Jordanstown
Reporting in CRC screening
HPV Project Use Case Bazaar 2017
Task Force on Cervical Cancer Screening in Estonia
528,000 new cases 266,000 death 90 % of the deaths in LMIC
Knowledge, Attitudes, and Practices Regarding Cervical Cancer and Screening Dr Ghufran Jassim MBBS,MD, MSc, PhD 8/30/2017.
Cervical Screening Programme
Cervical Cancer Surveillance, Screening, and Treatment
A decade of Latin-American experience with HPV prevention
African American and Hispanic Females and the Need for Early Detection
Epidemiology of cervical cancer in India: Where do we stand today
Presentation transcript:

Cervical cancer screening problems and barriers in Lithuania Presented by Ruta Kurtinaitiene Tallin April 2, 2007

It’ look’s like a hurdle-race in Lithuania Are we going to fight cervical cancer?

Cervical cancer Region IncidenceMortality World More developed countries Less developed countries LITHUANIA Source: Globocan 2002

Cervical cancer in EU 2004 Source: Globocan 2002

Cervical cancer screening in Lithuania: CA in situ and invasive cancer CA in situ invasive cancer

Cervical cancer in Lithuania 2005 Almost 7% of female malignant tumors

THE EUROCHIP-2 IN LITHUANIA Organisation of the national group Involvement in the Eurochip pilot studies Collection of information on available data Analysis of available data Production of reports on cancer health planning Connection with health planners and political makers in order to promote actions

Health services in urban and rural areas

Structure of consumers expenditures Unemployment rate, total and by sex 2002 year: 13.8 both sexes, 14,6 male, 12,9 female.

Cervical cancer screening in Lithuania Nation - wide screening started from July 1, woman at age are on the target with interval of 3 years

Cervical cancer screening in Lithuania Distribution of funding – REIMBURSEMENT FOR THE SERVICE (invitation, smear taking, PAP assessment) Invitation system – DECENTRALIZED PAP smear taking – DECENTRALIZED Reimbursement for PAP + LAB = approx 6 Eur

Better financing – better results?  Program financing 2004 m Lt ( EUR) 2005 m Lt ( EUR) 2006 m. – Lt ( EUR)... more than 50% committed funds are not used Program problems... but... still no centralised invitation system

Survey to identify the screening barriers Two surveys has been carried out to identify the screening barriers in the country. Two municipalities has been selected to test the possibilities of introduction of centralized invitation system –computerized system with centralized call/recall system and distribution of invitations to the woman which does not attended the programme (approx woman are on the target) First survey:

The invitation to join the programme Municipality B: Invitation mailed to the woman with detailed information on cervical cancer and the major risk factors. The mailing was supported by the information campaign by volunteers Municipality A: Invitation mailed to the woman with information to visit the primary health care center

Survey to identify the screening barriers Questionnaire on attitude on screening programm, the visits to gynecologist, knowledge of risk factors and HPV Next survey:

Results of survey on invitations Respond rate in rural municipality on mailed invitation was low (approx. 30%) Respond rate on distributed invitation by volunteers was reasonable (approx. 60%, the data is pending) The additional information that was provided to the woman was found useful to increase the attendance rates

Results of survey on knowledge Number of woman – 1075 Mean age – 33 years Questions: –Do You know about the programme – 80% –How frequently You are visiting gynecologist: one or twice a year – 34% never or rare – 65.4% –When the first PAP smear should be taken when start the sexual life – 53% since 18 years – 24% – Have You heard about HPV – 64% –have You heard about vaccines – 59% Low frequency of visits to gynecologist and insufficient information on the disease from other sources does not allow the woman to be more active on screening

Do you know about cervical screening programme? AgeYesNoTotal <30571 (75.93%) 180 (23.94%) (92.76%) 17 (5.86%) 290 >6025 (75.76%) 7 (21.21%) 33 Total865 (80.47%) 204 (18.98%) 1075

Frequency visit to gynecologist Age1-2 time a year Never or rare Total <30191 (25.39%) 561 (74.6%) (55.86%) 128 (43.79%) 290 >6017 (51.51%) 15 (45.45%) 33 Total370 (34.42%) 703 (65.4%) 1075

Do you know about HPV? AgeYes NoTotal <30454 (60.37%) 295 (39.23%) (72.07%) 75 (25.86%) 290 >6024 (72.73%) 5 (15.15%) 33 Total687 (63.91%) 375 (34.88%) 1075

Summary Despite of state support of cervical cancer screening, the barriers in implementation of the screening programme still exits The barriers are: –System related - the lack of centralized invitation system –Patient related – the lack of knowledge on existing prevention programme and risk factors Active actions should be take to overcome system and patient related barriers in order to reduce mortality rates from cervical cancer in Lithuania

Thank you